Skip to main content

Blog

Quality Equity Measure (NEW) – Flu Vaccination

Northwestern Medicine recently released its first set of quality equity metrics (both across the organization and for individual physicians), focused on influenza vaccination rates in the primary care setting. This is an important example of how QI can address disparities in care – more to come on this area in the future!

Some key take-home points on influenza vaccination:

  • Black, Hispanic and American Indian persons have higher rates of severe influenza infection (#1)
  • Last year at NMH, our AA patients declined the flu vaccine at twice the rate of their white peers
  • There are various reasons patients don’t get the vaccine – many of which are actionable

What you can do to help reduce disparities in flu vaccination rates:

  • There is evidence that a strong recommendation from you as their physician makes a difference! (#2)
  • Review this tip sheet on how to counsel patients with different concerns about the flu vaccine

https://nmhealth.sharepoint.com/:b:/r/sites/nmh-epid-inf-prot/SiteAssets/SitePages/nmh-epid-inf-prot/How-to-Increase-Flu-Vaccine-Confidence–Myths-Facts–FINAL-8-30-21–002-.pdf?csf=1&web=1&e=taiFez

  • Review this video that can be shared with staff and patients alike

https://players.brightcove.net/4598493596001/rk6CvVAel_default/index.html?videoId=6209385392001

 

-Mike

REFERENCES

  1. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2783448?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082421&ACSTrackingID=USCDC_7_3-DM64507&ACSTrackingLabel=Flu%20Vaccine%20Recommendations%20for%20the%202021-2022%20Flu%20Season&deliveryName=USCDC_7_3-DM64507
  2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861789/pdf/khvi-14-03-1376152.pdf

Inpatient Resident Quality Metrics at NMH – A Brief History and Future Directions

 

Hey everyone!

You all recently received inpatient quality metrics as well as some email communication to accompany them. The slides attached to this post contain some information on the history of this initiative, specific information on how the metrics were defined, as well as your peer resident physicians from the quality committee in years past who helped start the project and selected the metrics (you may see some familiar faces!).

 

Here’s some take-home points:

History: These reports are the product of a joint initiative by 5 residency programs (orthopedic surgery, anesthesiology, OB/GYN, internal medicine, and general surgery) to develop specialty-specific quality metrics for residents within each program

Objective of the program: Along with meeting ACGME requirements, the goal of the program is to provide low-stakes exposure for residents to individual quality measurement (these reports in residency will not be used as evaluation)

Rationale/Importance: we already receive outpatient quality metrics. Despite most of our training being inpatient, we did not previously have a formalized way of getting inpatient metrics. The goal is to help us reflect on our care to potentially act and improve the care we provide for our patients

Future: this is a work in progress and your feedback is welcome! If you have questions or feedback on how metrics can be more helpful, you can write to your chief residents or email academicaffairs@nm.org

Mike

USPSTF expands low-dose CT screening for lung cancer

The United States Preventive Services Task Force updated its 2013 lung cancer screening guidelines in March 2021 to expand the population that should be screened. The recommendation for low dose chest CT screening now includes adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.

Rationale:

  • Relative to the 2013 USPSTF screening program of patients aged 55-80 with 30 year pack-year history,  modeling analysis of the new recommended screening guidelines suggest lung cancer mortality would be reduced by 13.0% vs 9.8%.
  • The new guidelines also help decrease racial and gender disparities. Studies have shown Black persons, LatinX persons, and women tend to smoke at lower intensities than White men, and are less often screened per the 2013 guidelines. The new guidelines will increase inclusion of these populations in lung cancer screening.

Who is affected?

  • Adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years

How to implement?

  • low dose CT every year for screening of lung cancer

Important considerations

  • USPSTF changes apply to commercial insurance plans covered by Affordable Care Act. These plans aren’t required to provide the expanded benefit until January of 2023, so it’s important to remind patients to check their benefits before scheduling.
  • Centers for Medicare & Medicaid Services criteria for lung cancer screening have not changed (still follow 2013 guidelines of adults aged 55-80 with history of 30 pack years or more of smoking and who have quit in the last 15 years or are currently smoking)

References:

US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Landefeld CS, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117. PMID: 33687470.

Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce (uspreventiveservicestaskforce.org)

written by Daina Ringus

QI Effort Update: Blood Tube Shortage Strategies

As you probably noticed, there have been multiple emails about the national blood collection tube shortage. What has led to this shortage? The pandemic not only increased demand for blood draws but also impacted national supply chains. The current national shortages are listed below.

Increasing inventory supply will take time, and the best way for we as physicians to help in the meantime with this shortage (expected to last until Summer 2022) is to implement conservation efforts.

However, this is also an opportunity to improve the value of care we provide to our patients. The ABIM’s Choosing Wisely initiative recommends against daily lab testing if there is evidence of clinical and lab stability. Unnecessary lab draws contribute to healthcare system costs, can increase patient discomfort, and can lead to iatrogenic anemia.

We can utilize labs with the add-on function from previous samples and then we can decide if we really need daily BMP/CBC or if we can space these out for stable patients to every other day.

Northwestern will implement the removal of the “daily 4 AM” option in EPIC on Tuesday 10/26. Lab orders can be placed one day ahead of time, and you can continue to use “routine 1 time in AM” for morning draws. Previously ordered labs prior to 10/26 will continue as “daily 4 AM”. Order sets that contain “daily 4 AM” labs will change to default “routine 1 time in AM” instead as well.

Exceptions to these rules include Heparin/Argatroban/Warfarin monitoring (Anti Xa, aPTT, INR, etc).

One tool to offset this is the temporary storyboard notification tab in EPIC to help catch labs that may be missing as listed on the left side of the patient’s EPIC chart as below.

You can also use the MyList column to quickly view which of your patients have labs ordered for the next morning on your list patient list home page as below. Make sure to double-check that you have necessary labs ordered for your patients before you sign out for the day by looking at the morning draws tab.

We know this has been a stressful time for everyone with the pandemic, but we can continue to provide the best care possible for our patients by using our resources more judiciously and switch from a reflexive approach to ordering daily CBCs and chem panels to a clinical value-based approach.

-Dylan

QI Effort Update: New Pancreatitis Order Set

Are you confused about how much fluid to give for a new pancreatitis diagnosis or if you really need that CT scan to confirm the diagnosis? Well, good news; Dr. Keswani and a multidisciplinary committee have developed an updated evidence-based order set for acute pancreatitis management in Epic. I have addressed four common topics and their updates with this new order set in the post.

Acute pancreatitis is the most common gastrointestinal indication for hospitalization in the United States, resulting in significant morbidity and cost. There is increasing evidence to support a best practice approach to acute pancreatitis to improve patient outcomes. Clinical guidelines have been established at NM, but adherence remains low. Current performance indicates opportunities to improve care for this patient population to reduce hospital length of stay and cost.

  • What type of fluid to order and how much?

Recent evidence suggests that hydration with 3 mL/kg/hr might reduce complications of acute pancreatitis. The most important period in the resuscitation of acute pancreatitis is within the first 24 hours. This updated order set includes the use of Lactated Ringers as the only IVF to use for rehydration and in the first 24 hours is goal-directed (initial bolus 20 mL/kg and maintenance fluids 1.5-3 mL/kg/hour). The order set then gives options after 24 hours for IVF boluses and maintenance fluids pending the clinical picture.

  • When to get imaging? What modality?

The use of CT/MRI is not required for the diagnosis of pancreatitis if lipase is greater than three times the upper limit of normal and physical exam symptoms are consistent with pancreatitis. There is a link in the order set to clarify the need for imaging under ‘CT imaging guidance’ as listed below. Reasons to consider ordering imaging include diagnostic uncertainty (equivocal labs/history, concern for alternative process (e.g., MRI for choledocholithiasis or CT for intra-abdominal bleeding)), severe disease with instability (unstable vitals, BISAP >3), and failure to improve after > 48-72 hours. In patients with normal renal function, a CT scan with IV contrast of the abdomen can be obtained. If your patient has renal insufficiency, an MRI of the abdomen without intravenous contrast can be obtained.

  • When to feed patients? What is the longest we should wait? 

Patients should remain NPO for the first 12-24 hours of presentation to allow for an adequate assessment of symptoms and disease severity. Patients with mild acute pancreatitis or patients who are clinically improving and report feeling “ready” to begin an oral diet, can begin a low-fat solid oral diet as tolerated after 12-24 hours as listed in the order set. Severe pancreatitis should still be NPO initially and providers should monitor their progress with the help of consultation to the Dieticians. The Dieticians can be a great resource to help manage your patients and give support in restarting feeding and management moving forward in patient recovery.

  • When to consider ICU admission?

There are no currently available risk calculators that have both high sensitivity and specificity in predicting patients at high risk for severe acute pancreatitis and thus requiring ICU admission. We recommend that BISAP and SIRS scores and relevant comorbidities (renal insufficiency and congestive heart failure, obesity, and elevated triglycerides) be considered and documented on hospital presentation as these will affect resuscitation goals and management. Providers should strongly consider ICU admission for any patient with a BISAP score of at least 3 or > or equal to SIRS 3 as these are predictive of severe acute pancreatitis. In select patients with a BISAP score of 2 or SIRS < 3, it may be appropriate to consider ICU admission as well. These scores can be calculated as below.

BISAP Score; scored 0-5 based on number of positive criteria at admission.

  1. Blood Urea Nitrogen > 25
  2. Impaired Mental Status
  3. > or equal to 2 SIRS criteria
  4. Age > 60 years
  5. Pleural effusion (on chest x-ray)

SIRS Criteria

  1. Temperature < 36C or > 38C
  2. Heart rate > 90 bpm
  3. Respiratory rate > 20 breaths/minute
  4. White blood cell count < 4,000 cells/mm3 or > 12,000 cells/mm3

– Dylan

Get involved – join a QI subcommittee!

Hey Team!

If you’re a current PGY2 or PGY3, consider joining a QI subcommittee!

Whether it’s gaining a deeper understanding of a subspecialty you’re interested in or getting a unique perspective on hospital leadership and operations, the QI subcommittees are a low-stress and valuable way to learn and get involved.

See here for a list of residents involved last year in the QI subcommittees: https://sites.northwestern.edu/imqicommittee/qi-subcommittees/

Available subcommittees include:

– Sepsis sub-committee (very active and involves many different disciplines in the hospital + ongoing developments with the sepsis predictive analytics model in Epic)

– Glycemic control subcommittee (great for budding endocrinologists and GIM especially

– NETS Working Group (reviews medication-related patient safety events)

– Peer Review Committee (interdisciplinary group examining general patient-safety events)

*We are still waiting to hear back from leadership, but stay tuned on opportunities to join the Shock/VA ECMO (aspiring cardiologists and critical care docs) + VV ECMO (future pulmonary/critical care docs) subcommittees in the future.

Reach out to Mike Jiang at michael.jiang2@northwestern.edu if interested, including for the VA and VV ECMO subcommittees so that you are first on the list to be contacted once opportunities become available.

TWDFNR: Serologic H. pylori Testing

Hey team!

I am writing to share a high-value care pearl this week from the Things We Do For No Reason (TWDFNR) series! For those who haven’t read before, the Journal of Hospital Medicine’s TWDFNR series was inspired by ABIM’s Choosing Wisely Campaign and highlights practices that have become common in medicine but don’t necessarily add value for our patients.

This week, we will focus on serologic testing for H. pylori. Here are some highlights from an article by Xu and Graham, published  7/2021 in JHM.

-The preferred noninvasive diagnostic tests for H. pylori are the urea breath test and the stool antigen test (both are send-out and have a turn-around time of 2-6 days). For patients who get an endoscopy, histopathologic testing is also a preferred diagnostic method.

-Serologic testing is cheap, immediate, and convenient. However, the main drawback is that it cannot distinguish between active and prior infection, reducing its specificity.

-Why you might think serologic testing is helpful: Patients admitted for a GI bleed from peptic ulcer disease are appropriately started on PPIs in the hospital. PPIs, bismuth, and antimicrobials can all reduce the sensitivity of biopsy and stool and urea breath tests, but do not affect serologic testing.

However, there is no evidence that an immediate diagnosis of H. pylori improves patient outcomes. Many can safely complete a course of PPI therapy and be re-tested as an outpatient 4 weeks after completion of PPI therapy.

-Situations where serologic testing can be acceptable: high clinical pre-test probability – peptic ulcer disease on endoscopy without other risk factors who have reasons to have a potentially false-negative biopsy result (MALT lymphoma, treatment with PPIs/bismuth/antimicrobials, active ulcer bleeding during endoscopy). A positive serologic test here (provided they have not been positive before on testing) may prompt empiric initiation of eradication therapy. This may be especially helpful if you have concerns about a patient’s ability to follow-up.

-If you pursue serologic testing, only the IgG should be used. The IgA and IgM assays are available but are not FDA-approved and have poor diagnostic performance.

References:

https://www.journalofhospitalmedicine.com/jhospmed/article/243002/hospital-medicine/things-we-do-no-reasontm-serum-serologic-helicobacter?channel=27621

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864555/

 

 

 

Chicago Health Alert Network: Legionella Rising

We received an update from healthcare epidemiologists on a rise in Legionella detected in the community in Chicago. 16 cases have been reported to the Chicago Department of Public Health since July 1st 2021 and are currently under investigation. Here are a few clinical pearls:

-Consider Legionella in anybody presenting with a pneumonia. Risk factors include age > 50yo, a smoking history, chronic lung or immunocompromising conditions

-Diagnostic testing: The preferred diagnostic test is isolation on a sputum or BAL culture (this is a separate order in Epic specifically for Legionella). Urinary antigens can also be sent but will only detect serogroup 1 (which is most prevalent but there are 15 groups!) – testing for this serogroup may have a sensitivity 70-100% and specificity 95-100%.

-Reporting: REPORTING/CONTACT INFORMATION:   Legionella cases should be reported to Chicago Department of Public Health by calling 312-743-9000 or via the Illinois National Electronic Disease Surveillance System (INEDSS).

Sources:

https://www.cdc.gov/legionella/clinicians/diagnostic-testing.html

PAWSS: Easy Screening for High-Risk Alcohol Withdrawal

I wanted to take a moment to highlight a 2019 QI project at NMH 

Alcohol use disorders is a common illness among hospitalized patients. A 2015 epidemiological study found the 12month prevalence of alcohol use disorder among adults to be 13.9%.Identification of patients at high risk for complicated withdrawal (seizures, delirium tremens and severe alcohol withdrawal symptoms) is crucial to provide the appropriate treatment to patients. In addition, it also helps minimize unnecessary benzodiazepine use and undue strain on nursing staff by performing frequent CIWA questionnaires.  

PAWSS is a validated one-time screening tool that has been demonstrated to identify those at high-risk for complicated alcohol withdrawal syndrome. A score greater or equal to 4 was demonstrated to have a specificity and sensitivity of 99.5% and 93.5% respectively. 2 

As part of the QI project, the team in 2019 created a PAWSS order set that will reflex to CIWAs q4h for patients that score 4 or higher. Keep this easy-to-use order set in mind next time you have a patient you’re concerned for potential alcohol withdrawals.  

Resources:

  1. Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015 Aug;72(8):757-66.
  2. Maldonado JR, Sher Y, Das S, Hills-Evans K, Frenklach A, Lolak S, Talley R, Neri E. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. Alcohol Alcohol. 2015 Sep;50(5):509-18.

USPSTF

The United States Preventative Service Task Force (USPSTF) is an organization focused on providing high-quality, evidence based recommendations regarding clinical preventative services. The USPSTF is a great resource that I wanted to highlight in today’s post.

Each recommendation from the USPSTF receives a grade based on the below definitions.

Since 2020, they have made 8 new grade A or B recommendations. Notably, they recommended screening adults aged 18-79 for Hepatitis C (Grade B). A complete list of grade A and B recommendations can be found here.

To help out during a busy day in clinic, they have created an app (compatible with Apple and Android devices) to easily identify screening, counseling and preventative medication services for patients. The app can be found here. 

 

Please see their website for the most up to date information.

USPSTF Website: Home page | United States Preventive Services Taskforce (uspreventiveservicestaskforce.org)

Group A and B Recommendations: A and B Recommendations | United States Preventive Services Taskforce (uspreventiveservicestaskforce.org)

USPSTF App: U.S. Preventive Services | Prevention TaskForce (uspreventiveservicestaskforce.org)